Showing results (31-40 of 747) with videos related to
Sort By:
Pageof 75
American Heart Journal|July 31, 2008
Pharmacology of emerging novel platelet inhibitorsDominick J Angiolillo, Piera CapranzanoAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 27, 2010
Platelet P2Y₁₂ receptor inhibition: an update on clinical drug developmentDavid Vivas, Dominick J AngiolilloBest Practice & Research. Clinical Endocrinology & Metabolism|June 13, 2009
Aspirin and clopidogrel: efficacy and resistance in diabetes mellitusDominick J Angiolillo, Siva SuryadevaraNature Reviews. Cardiology|October 8, 2014
Novel antiplatelet agents in acute coronary syndromeFrancesco Franchi, Dominick J AngiolilloCirculation|October 13, 2016
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes MellitusDavide Capodanno, Dominick J AngiolilloJournal of Clinical Medicine|November 11, 2022
Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for PracticeFelice Gragnano, Antonio Capolongo, Fabrizia Terracciano, et al.Current Cardiology Reviews|December 11, 2020
Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and DifferencesAndreas Mitsis, Felice GragnanoAtherosclerosis|February 7, 2018
Role of dual lipid-lowering therapy in coronary atherosclerosis regression: Evidence from recent studiesFelice Gragnano, Paolo CalabròJournal of Thrombosis and Thrombolysis|August 29, 2014
Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemmaJung Rae Cho, Dominick J AngiolilloAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 25, 2013
Antiplatelet and anticoagulant therapy for atherothrombotic disease: the role of current and emerging agentsDominick J Angiolillo, José Luis FerreiroPageof 75